$16.10
0.221.39%
At Close: -
$16.08
-0.02-0.12%
After Hours: 5:10 PM EDT
15 minutes delayed
UroGen Pharma
URGNNASDAQ
UroGen Pharma (URGN) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestUroGen Pharma (NASDAQ:URGN) Stock Quotes, Forecast and News Summary
UroGen Pharma Stock (NASDAQ: URGN) stock price, news, charts, stock research, profile.
| Open | $15.98 |
| Close | $16.10 |
| Volume / Avg. | 357.53K / 609.98K |
| Day Range | 15.90 - 16.46 |
| 52 Wk Range | 8.69 - 24.13 |
| Market Cap | $662.01M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 53 |
| Short Interest | 13.99% |
| Days to Cover | 4.18 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About
Sector
Healthcare
Industry
N/A
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in innovative solutions for ur...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy UroGen Pharma (URGN) stock?
You can purchase shares of UroGen Pharma (NASDAQ:URGN) through any online brokerage.
Who are UroGen Pharma (URGN) competitors?
There are no as such competitors for UroGen Pharma.
What is the target price for UroGen Pharma (URGN) stock?
There is no analysis for UroGen Pharma.
What is the forecast for UroGen Pharma (URGN) stock?
UroGen Pharma has a consensus price target of $33.58.
Current stock price for UroGen Pharma (URGN)?
The stock price for UroGen Pharma (NASDAQ: URGN) is $16.08 last updated Today at July 8, 2024 at 5:10 PM EDT.
Does UroGen Pharma (URGN) pay a dividend?
There are no upcoming dividends for UroGen Pharma.
When is UroGen Pharma (NASDAQ:URGN) reporting earnings?
UroGen Pharma’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is UroGen Pharma (URGN) going to split?
There is no upcoming split for UroGen Pharma.
What sector and industry does UroGen Pharma (URGN) operate in?
UroGen Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.